Published : 03 Jun 2019

---

Aagami will support out-licensing in India and selective other regions for an Israel based BioPharma Company with ‘Novel Treatment for Non-Surgical Removal of Skin Lesions (incl. corns, warts, skin tags).

 

The product is already on the OTC market (EU and selected additional territories). 

 

Aagami team look forward to helping it new client make this great product available to more and more people in the world via strategic licensing partnerships.